Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Ziv Raviv"'
Autor:
Madeleine Benguigui, Avital Vorontsova, Michael Timaner, Sapir Levin, Jozafina Haj-Shomaly, Abhilash Deo, Rotem Menachem, Bar Manobla, Tim J. Cooper, Ziv Raviv, Yuval Shaked
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Myeloid-derived suppressor cells (MDSCs) are known to promote tumor growth in part by their immunosuppressive activities and their angiogenesis support. It has been shown that Bv8 blockade inhibits the recruitment of MDSCs to tumors, thereby delaying
Externí odkaz:
https://doaj.org/article/dfdc5e1ca1d0488799c8de402783321b
Autor:
Michael Timaner, Ziv Raviv, Shai Shen-Orr, Yuval Shaked, Tongwu Zhang, Ksenia Magidey-Klein, Tim J Cooper, Ksenya Kveler, Rachelly Normand, Brian P. James, Roi Gazit, Ze'ev A. Ronai
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Background Metastasis is the major cause of death in patients with cancer. Myeloid skewing of hematopoietic cells is a prominent promoter of metastasis. However, the reservoir of these cells in the bone marrow (BM) compartment and their differentiati
Externí odkaz:
https://doaj.org/article/b1eb6c9ab4594ba7bc4b1dc99865ddec
Autor:
Michael Timaner, Ziv Raviv, Shai Shen-Orr, Yuval Shaked, Tongwu Zhang, Ksenia Magidey-Klein, Tim J Cooper, Ksenya Kveler, Rachelly Normand, Brian P. James, Roi Gazit, Ze'ev A. Ronai
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Externí odkaz:
https://doaj.org/article/d52b571268c14be3a4db3fc9ccc60dcd
Autor:
Ziv Raviv, Yuval Shaked, Michal Harel, Eyal Jacob, Irina Khononov, Ella Fremder, Nili Dahan, Boris Krastev
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Background Immune checkpoint inhibitors (ICIs) have made a paradigm shift in clinical oncology due to unprecedented long-term remissions. However, only a small proportion of patients respond to ICI therapy. It is, therefore, essential to understand t
Externí odkaz:
https://doaj.org/article/bff6b185724a475bb156ddba2d7316bc
Autor:
Dror Alishekevitz, Svetlana Gingis-Velitski, Orit Kaidar-Person, Lilach Gutter-Kapon, Sandra D. Scherer, Ziv Raviv, Emmanuelle Merquiol, Yael Ben-Nun, Valeria Miller, Chen Rachman-Tzemah, Michael Timaner, Yelena Mumblat, Neta Ilan, David Loven, Dov Hershkovitz, Ronit Satchi-Fainaro, Galia Blum, Jonathan P. Sleeman, Israel Vlodavsky, Yuval Shaked
Publikováno v:
Cell Reports, Vol 17, Iss 5, Pp 1344-1356 (2016)
Summary: While chemotherapy strongly restricts or reverses tumor growth, the response of host tissue to therapy can counteract its anti-tumor activity by promoting tumor re-growth and/or metastases, thus limiting therapeutic efficacy. Here, we show t
Externí odkaz:
https://doaj.org/article/33aac968c8234da399706c8ab64ff755
Autor:
Erez Hasnis, Dror Alishekevitz, Svetlana Gingis-Veltski, Rotem Bril, Ella Fremder, Tali Voloshin, Ziv Raviv, Amir Karban, Yuval Shaked
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 16, Iss 6, Pp 501-510 (2014)
Weekly gemcitabine therapy is the major treatment offered for patients with pancreatic adenocarcinoma cancer; however, relative resistance of tumor cells to chemotherapy, rapid regrowth, and metastasis are the main causes of death within a year. Rece
Externí odkaz:
https://doaj.org/article/c32c6a1bb72a498288dcacb31ab59eb1
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e105188 (2014)
Mycoplasma iowae is a well-established avian pathogen that can infect and damage many sites throughout the body. One potential mediator of cellular damage by mycoplasmas is the production of H2O2 via a glycerol catabolic pathway whose genes are wides
Externí odkaz:
https://doaj.org/article/1de9b85fb4b947d2ae7c4a523a843ea1
Publikováno v:
PLoS ONE, Vol 5, Iss 9, p e12627 (2010)
The ERK5 cascade is a MAPK pathway that transmits both mitogenic and stress signals, yet its mechanism of activation is not fully understood. Using intracellular calcium modifiers, we found that ERK5 activation by EGF is inhibited both by the depleti
Externí odkaz:
https://doaj.org/article/008569ecaa6c4a98bcba90a4fc8ade63
Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors
Autor:
Avital Vorontsova, Tim J. Cooper, Jozafina Haj-Shomaly, Madeleine Benguigui, Sapir Levin, Bar Manobla, Rotem Menachem, Michael Timaner, Ziv Raviv, Yuval Shaked
Publikováno v:
Oncogene. 42:771-781
Chemotherapy remains one of the main treatment modalities for cancer. While chemotherapy is mainly known for its ability to kill tumor cells directly, accumulating evidence indicates that it also acts indirectly by enhancing T cell-mediated anti-tumo
Autor:
Yuval Shaked, Ruth Scherz-Shouval, Daphne Weihs, Peleg Hasson, Shay Soker, Tim J. Cooper, Ziv Raviv, Michael Timaner, Mahesh Devarasetty, Oshrat Levi-Galibov, Tamar Barenholz-Cohen, Avital Vorontsova, Jozafina Haj-Shomaly
supplemental materials and methods and supplemental figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f34a0f5448f772aab33f594ffb1f4bc
https://doi.org/10.1158/0008-5472.22582427.v1
https://doi.org/10.1158/0008-5472.22582427.v1